Case Report: Successful treatment of steroid- and ruxolitinib-refractory gastrointestinal acute graft-versus-Host disease with anti-thymocyte globulin
Acute graft-versus-host disease (aGVHD), particularly with gastrointestinal (GI) involvement, remains a life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). Despite corticosteroids and ruxolitinib as first- and second-line therapies, up to 50% of patients de...
Saved in:
| Main Authors: | Lulu Zhang, Fan Wu, Huiping Wang, Zhimin Zhai, Lili Tao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610071/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
by: Aviran Aharon, et al.
Published: (2025-04-01) -
The microbiome in graft-versus-host disease: a tale of two ecosystems
by: Hamed Soleimani Samarkhazan, et al.
Published: (2025-07-01) -
Enhance the therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in prevention of acute graft-versus-host disease through CRISPLD2 modulation
by: Qing Xu, et al.
Published: (2025-05-01) -
CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients
by: Rui Liu, et al.
Published: (2025-05-01) -
Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)